Surgical Snares Market Size & Share 2025 - 2034

Surgical Snares Market Size

The global surgical snares market was valued at around USD 1.3 billion in 2024. The market is expected to reach from USD 1.4 billion in 2025 to USD 2.6 billion in 2034, growing at a CAGR of 6.8% during the forecast period. The high market growth is attributed to the rising incidence of gastrointestinal diseases, advancements in endoscopic technologies, rising healthcare expenditure and infrastructure, growing geriatric population, and among other contributing factors.

The rising incidence of colorectal cancer, polyps, and inflammatory bowel disease increases the demand for endoscopic procedures. According to the American Cancer Society, approximately 153,020 new cases of colorectal cancer were reported in 2023, with an estimated 106,970 cases of colon cancer and 46,050 cases of rectal cancer. The World Health Organization reported that inflammatory bowel disease affected about 10 million people globally in 2022. Surgical snares, which are essential instruments for polypectomy and mucosal resection procedures, contribute to the market's expansion.
 

Moreover, the market for surgical snares is expanding owing to the growing number of ambulatory surgery centers performing polypectomies as well as the greater demand for less invasive surgical techniques. In the U.S., there are now more than 6,000 Medicare-certified ambulatory surgery centers, which marked a 12% increase in 2021, according to the Ambulatory Surgery Center Association (ASCA). Similarly, the Centers for Medicare & Medicaid Services (CMS) indicated that, in 2022, roughly 68% of all outpatient surgical procedures in the U.S. were conducted in ambulatory surgery centers, an increase from 63% in 2021.
 

Surgical snares are used to excise abnormal tissue or foreign bodies within the confines of an endoscopic operation. Surgical snares are crafted from fine, pliable wire which is formed into a loop on one end; they can be made to grasp and retrieve tissue or foreign objects from the gastro-intestinal tract, bladder, and other cavities of the body. Surgical snares are widely used in many endoscopy procedures such as colonoscopies, esophagogastroduodenoscopies (EGDs), and bronchoscopes.
 

Surgical Snares Market Trends

The market is witnessing significant growth driven by rise in outpatient endoscopic procedures, growing need for integrated advanced materials and ergonomic designs, shift toward single-use (disposable) snares, and continuous innovations with imaging systems, among other factors are boosting the industry growth.
 

• The market is witnessing a strong shift towards disposable snares designed to minimize the risk of cross-contamination as well as hospital-acquired infections. For instance, The Centers for Disease Control and Prevention (CDC) reported that one in 31 patients in hospitals had a healthcare-associated infection in the year 2022. On the other hand, the FDA recorded a 35% surge from 2021 to 2023 in the endorsement of single-use-endoscopic devices. SUDs (Single-Use Devices) instruments negates the need for sterilization, therefore, saving time and resources for healthcare providers. This trend is mostly noticeable in developed markets where infection control is placed at high importance. Moreover, it allows for quicker turnaround in high-volume multi-day outpatient surgery centers (MASC) or clinics.
   
• The industry is focusing on snares produced from newer, more flexible, biocompatible materials which improves maneuverability and safety to the healthcare personnel. In addition, manufacturers are also introducing more ergonomic handles along with better rotational control for enhanced comfort and accuracy during the procedures. These design improvements are geared towards faster and more efficient outcomes. This trend is preferred by the physicians and boosts operational effectiveness.
   
• Furthermore, the market for specialized snares like cold snares, hexagonal loop snares, and rotatable snares continues to grow to satisfy diverse clinical requirements. An example of this is cold snaring, which is becoming widely accepted for the removal of smaller polyps since it no longer requires the use of electrocautery, which preserves tissue. Modification enables gastroenterologists to customize the procedures to fit the type, size, and location of the polyp. This shifts rationale advances in treatment towards patient-defined approaches while enhancing clinical adaptability, contributing to the growing market demand.
   

Trump Administration Tariffs

• Trump's administration may affect the U.S. surgical snares market since majority of medical devices are imported in the U.S. About 69% of medical devices in the U.S. are manufactured outside the country, these tariffs may cause significant increase in production costs for many local manufacturers.
   
• Companies such as, L&K Biomed and others serving the overseas market will bear the brunt. Their supply chains are already strained and there is no end in sight to their higher pricing woes. Surgical snares will be earmarked as costlier medical devices, limiting their access available to patients who really are in need due to added costs provided by healthcare providers.
   
• Moreover, the additional proposed tariff on all Chinese imported goods will worsen this issue since major chunk of medical devices marketed in the U.S. are produced in China. This legislation will likely exacerbate an already tenuous situation by further stalling the supply chain, creating more shortages, and delaying the delivery of surgical snares.
   
• Even with the tariffs attempting to stimulate domestic output, the industry operating the devices must deal with the tower spiraling operational expenses and risks in the industry. To lessen the impacts of these unbalanced trade policies, industries may need to relocate the headquarters of their business to the country of economics engaged in free trade to re-evaluate their supply chains.
   

Surgical Snares Market Analysis

Based on usability, the market is segmented as single-use and reusables. Single-use segment dominated the market in 2024 accounting for more than 61.1% of the total market share.
 

• This dominant market share is primarily owing several advantages of being cost-effective, lower risk of contamination, high efficiency, and easy to use factor. Due to the aforementioned factors, these products are widely preferred during surgical procedures, thereby driving the product demand & sales volume.
   
• Further, disposable surgical snares eliminate the risk of cross-contamination and infection associated with the reuse of surgical instruments and offer convenience, as these snares are pre-sterilized and ready to use, which saves time & reduces the need for sterilization equipment and processes.
   
• Additionally, single-use devices in some procedures are preferred or made mandatory by implementation bodies and accreditation bodies. Guidelines from organizations such as the CDC and FDA advocate for the use of disposable instruments in order to reduce healthcare-associated infections. These regulations are shifting purchasing policies in hospitals and clinics. Therefore, the factors stated above are expected to considerably accelerate the growth of the market during the analysis period.
   

Based on application, the surgical snares market is segmented as GI endoscopy, laparoscopy, cystoscopy, arthroscopy, bronchoscopy, gynecology endoscopy, and other applications. The GI endoscopy segment is expected to drive business growth and expand at a CAGR of 7.1%, reaching over USD 806.7 million by 2034.
 

• The rising global incidence of colorectal cancer and its precancerous polyps drives the growth of gastrointestinal (GI) endoscopy procedures. The American Cancer Society estimates that there were around 153,020 new colorectal cancer cases in 2023 along with an estimated 52,550 deaths. The World Health Organization stated that colorectal cancer was the third most diagnosed cancer in the world in 2022, with a staggering 1.93 million cases.
   
• Snares are still the standard polypectomy tools used during colonoscopy procedures. According to National Cancer Institute data, these procedures, along with timely intervention, allow the mitigation of colorectal cancer risk by 90% as of 2023, which increases the need for GI endoscopic instruments.
   
• The introduction of high-definition and narrow-band imaging endoscopes has resulted in better visualization and, as such, an increase in the detection and identification of mucosal abnormalities. Increased detection of polyps further escalates demand for efficient snaring tools. Enhanced diagnostic precision is associatively important to the increased use of snares in GI procedures, subsequently leading to sectional growth.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the surgical snares market is classified into hospitals, ambulatory surgical centers, and other end users. The hospitals segment dominated the market with a revenue share of 59.3% in 2024.
 

• Hospitals manage a wide range of gastrointestinal cases, including complex or high-risk patients requiring advanced endoscopic procedures. The consistent demand for diagnostic and therapeutic endoscopies increases the usage of surgical snares. Their role in polypectomy and mucosal resection makes them essential tools in hospital settings.
   
• In terms of advanced endoscopy systems, imaging systems, and other specialized instruments, hospitals tend to be better ranked. With these resources, advanced snares can be employed for EMR (Endoscopic Mucosal Resection) and ESD (Endoscopic Submucosal Dissection). The heightened infrastructure facilitates greater accuracy in procedural execution and snare usage.
   
• In addition, numerous hospital-based procedures, such as GI endoscopies, receive coverage from public and private insurance providers. Reimbursement policies that support polypectomy and other snare-based procedures incentive hospitals to increase the performance of these interventions. Such reimbursement policies aid in sustaining investments in equipment and volume of procedures performed, leading to segmental growth.
   

 

U.S. surgical snares market accounted for USD 531.8 million in 2024. The U.S. dominated the global market in 2023 with USD 496.9 million growing from USD 477 million in 2022 and is anticipated to grow at a CAGR of 5.8% between 2025 to 2034 period.
 

• The U.S. has a high incidence of colorectal cancer, with approximately 153,020 new cases recorded in 2023, according to the American Cancer Society. Government initiatives, including the Centers for Disease Control and Prevention's Colorectal Cancer Control Program (CRCCP), which received USD 43 million in funding for FY 2023, encourage regular colonoscopies that require snares for polyp removal.
   
• The CDC indicated that colonoscopy screening rates rose from 63.7% in 2021 to 67.2% in 2023 within the 50 to 75 aged adult demographic. Market growth is greatly aided by these screenings and detection programs.
   
• The healthcare system in the U.S. has ultra-modern endoscopy and laparoscopy systems. Advanced hospitals and surgical centers procure sophisticated design and cutting precision snares. This encourages the quick uptake of high-quality, often disposable, instruments.
   
• Patients undergoing procedures in the country require less invasive approaches because of improved recovery time, which drives preference for these techniques. Surgical snares are omnipresent in endoscopic procedures such as EMR and polypectomy. This meets expectations in the healthcare system in relation to spending and delivery efficiency.
   

Germany surgical snares market in the Europe is projected to grow remarkably in the coming years.
 

• In Germany, the colorectal cancer screening programs are specifically designed to endorse periodic endoscopic checkups and comfort checkups for people above 50 years of age. These programs facilitate the early detection and removal of polyps which increases the market for surgical snares. Sick funds and public service health campaigns further sustain high screening participation.
   
• Endoscopic systems in German hospitals are of high quality, and rigid clinical protocols are adhered to. Such an environment increases the use of high quality snares during diagnostic and therapeutic gastrointestinal procedures. The need is particularly acute in academic and tertiary care hospitals.
   
• In addition, there are a number of high quality manufacturers of endoscopy and surgical instruments located in the country. This guarantees innovation and easy access to advanced snare technologies such as single-use devices. Regional production and advanced domestic R&D improve responsiveness and availability of these products. These above factors are anticipated to boost the market growth in the country.
   

Japan holds a dominant position in the Asia Pacific surgical snares market.
 

• The government of Japan promotes preventative health measures such as colonoscopy as well as gastroscopy for the aged. As reported by the Ministry of Health, Labour and Welfare, cancer screening uptake reached 48.4 percent in 2021 alongside 2.3 million performed endoscopic procedures.
   
• Spendings were directed towards an increase in cancer screening programs, receiving an allocation of USD 113.2 million in 2022. This incited a raise of 12% to endoscopic procedures. These figures are projected to reach 52% of the eligible population having received regular screenings by the National Cancer Center Japan in 2023, thus elevating the supply for surgical snares in ambulatory and hospital settings.
   
• Additionally, the elderly population in Japan is driving an increase in the demand for gastrointestinal maintenance care. As per the Japanese Ministry of Health, Labor and Welfare, people aged 65 and older account for 29.1% of the population as of 2021 projected to rise to 30.9% by 2024.
   
• In 2022, the National Cancer Center Japan claimed 45% of cancers in Japan were gastrointestinal in nature and there were 150,000 annual procedures performed. This population change drives more procedures performed, thus increasing the need for surgical snares.
   

The Brazil surgical snares market is experiencing robust growth in Latin America market.
 

• The public healthcare system of Brazil, Sistema Único de Saúde (SUS), has recently broadened the scope of access to diagnostic endoscopy services. Increased government efforts towards strengthening cancer screening and improving the overall infrastructure for gastrointestinal (GI) care are increasing the volume of procedures. This creates a need for public hospitals to source inexpensive and dependable surgical snares.
   
• The growth of private healthcare in Brazil, which now includes specialized GI clinics along with diagnostic laboratories, bolsters the use of advanced endoscopic instruments. These institutions tend to use modern, disposable snares due to their effectiveness in minimizing cross infection and maximization of streamlined workflow. The combination of both sectors is beneficial to the market and sustains demand.
   
• The expansion of the urban population with healthcare access, particularly in large cities like Sao Paulo and Rio de Janeiro, is contributing to the increasing number of GI procedures performed. The improved access to endoscopy tools and trained personnel facilitates the wider deployment of snares. Growth of the urban population is an important factor for demand.
   

Surgical Snares Market Share

Some of the major players operating in the surgical snares industry are Boston Scientific Corporation, Olympus Corporation, ConMed Corporation, Medline Industries, and Merit Medical Systems, account for approximately 65% of the market share. These leading market players are implementing advanced technologies to cater to the large unmet needs of the consumers. These players focus on strategic partnerships, new product launch & commercialization for market expansion. Furthermore, these players are heavily investing in research that allows them to introduce innovative products and garner maximum revenue in the market.
 

Surgical Snares Market Companies

Prominent players operating in the surgical snares industry include:

• aspen surgical
• Avalign Technologies
• Boston Scientific Corporation
• ConMed
• Cook
• EndoMed Systems
• GPC Medical
• Hill-Rom Holdings
• Medline
• Medtronic
• Merit Medical Systems
• Olympus
• Sklar Surgical Instruments
• STERIS
• Teleflex
   
• Boston Scientific offers a comprehensive range of surgical snares with various shapes and stiffness levels, including the advanced Sensation Short Throw Snare for improved handling. Their devices are designed for precision, flexibility, and procedural efficiency across multiple clinical applications.
   
• Olympus stands out with its SnareMaster and SnareMaster Plus, including hot/cold hybrid designs and unique hexagonal shapes for improved grip and cutting performance. The company also supports clinicians with robust training via its Olympus Continuum platform.
   
• Medtronic leverages its global reach and R&D strength to offer reliable disposable snares suited for GI and laparoscopic procedures. Its strategic partnerships and innovations focus on enhancing clinical outcomes and operational efficiency.
   

Surgical Snares Industry News

• In April 2021, Argon Medical Devices announced the U.S. launch of its Halo single-loop snare kits. The snare catheter’s creators designed it to provide both accuracy and reliability when retrieving and manipulating foreign objects from the cardiovascular system or hollow viscus, according to Argon Medical Devices. This launch helped the company to introduce innovative products, further offering a competitive edge.
   
• In October 2019, Olympus announced the U.S. launch of the SnareMaster Plus hybrid hot/cold snare. The Olympus-designed and manufactured SnareMaster Plus allows Olympus to cover all procedural applications for polypectomy through its SnareMaster portfolio, which includes the SnareMaster Soft and the SnareMaster Spiral. This product launch helped the company to strengthen its product portfolio across the U.S. market.
   

The surgical snares market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million and from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Usability

• Single-use
• Reusable

Market, By Application

• GI endoscopy
• Laparoscopy
• Cystoscopy
• Arthroscopy
• Bronchoscopy
• Gynecology endoscopy
• Other applications

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE